Big, Small Plans Split On Medicare Drug Price Negotiation

By John Wilkerson / October 13, 2021 at 2:00 PM

Small insurance companies are more likely than big insurers to support letting Medicare negotiate prices for the most expensive drugs in part because doing so would help smaller insurers compete on premiums with larger insurers, sources familiar with the industry say.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.